Municipal Employees' Retirement System Of Michigan Vertex Pharmaceuticals Inc Transaction History

Municipal Employees' Retirement System Of Michigan

$7.58 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 05, 2020	SELL	$255.65 - $303.1 $800,184 - $948,703	-3,130 Closed	0 $0
Q2 2020 Jul 06, 2020	SELL	$225.48 - $295.8 $126,268 - $165,648	-560 Reduced 15.18%	3,130 $909,000
Q1 2020 Apr 29, 2020	BUY	$199.77 - $247.81 $9,988 - $12,390	50 Added 1.37%	3,690 $878,000
Q4 2019 Feb 03, 2020	SELL	$166.71 - $223.91 $465,120 - $624,708	-2,790 Reduced 43.39%	3,640 $797,000
Q3 2019 Oct 29, 2019	BUY	$166.23 - $187.09 $9,973 - $11,225	60 Added 0.94%	6,430 $1.09 Million
Q2 2019 Jul 31, 2019	BUY	$164.61 - $190.37 $87,243 - $100,896	530 Added 9.08%	6,370 $1.17 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $556,682 - $661,980	-3,400 Reduced 36.8%	5,840 $1.07 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $376,736 - $476,680	2,480 Added 36.69%	9,240 $1.53 Million
Q2 2018 Jul 19, 2018	BUY	$145.72 - $169.96 $16,029 - $18,695	110 Added 1.65%	6,760 $1.15 Million
Q1 2018 May 10, 2018	BUY	$151.6 - $177.13 $21,224 - $24,798	140 Added 2.15%	6,650 $1.08 Million
Q3 2017 Nov 06, 2017	BUY	$148.13 - $162.24 $964,326 - $1.06 Million	6,510	6,510 $990,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.61 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.33 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.06 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Municipal Employees' Retirement System Of Michigan, based on Form 13F filings with the SEC.

News

Stay updated on Municipal Employees' Retirement System Of Michigan with notifications on news.

Account